AN OVERVIEW OF THE CLINICAL-PHARMACOLOGY OF N-PHOSPHONACETYL-L-ASPARTATE (PALA), A NEW ANTIMETABOLITE

被引：0
作者：
ERLICHMAN, C
机构：
来源：
RECENT RESULTS IN CANCER RESEARCH | 1980年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：65 / 71
页数：7
相关论文
共 16 条
[1]  
CHADWICK M, 1978, P AM ASSOC CANC RES, V19, P182
[2]  
COLLINS KD, 1971, J BIOL CHEM, V246, P6599
[3]  
ERLICHMAN C, 1979, P AM ASSOC CANC RES, V20, P314
[4]  
ERVIN TJ, 1979, P AM ASSOC CANC RES, V20, P200
[5]  
GRALLA RJ, 1979, P AM ASSOC CANC RES, V20, P115
[6]  
JAYARAM HN, 1979, CANCER TREAT REP, V63, P1291
[7]  
JOHNSON RK, 1976, CANCER RES, V36, P2720
[8]   REVERSAL OF TOXICITY AND ANTITUMOR ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTATE BY URIDINE OR CARBAMYL-DL-ASPARTATE INVIVO [J].
JOHNSON, RK .
BIOCHEMICAL PHARMACOLOGY, 1977, 26 (01) :81-84
[9]   STABLE MUTANTS OF MAMMALIAN-CELLS THAT OVER-PRODUCE 1ST 3 ENZYMES OF PYRIMIDINE NUCLEOTIDE BIOSYNTHESIS [J].
KEMPE, TD ;
SWYRYD, EA ;
BRUIST, M ;
STARK, GR .
CELL, 1976, 9 (04) :541-550
[10]  
KENSLER TW, 1979, P AM ASSOC CANC RES, V20, P243
12